GC genotypes associated with lower vitamin D levels – April 2012

Allelic Determinants of Vitamin D Insufficiency, Bone Mineral Density, and Bone Fractures

Olivia Trummer, Verena Schwetz, Daniela Walter-Finell, Elisabeth Lerchbaum, Wilfried Renner, Markus Gugatschka, Harald Dobnig, Thomas R. Pieber and Barbara Obermayer-Pietsch
Division of Endocrinology and Metabolism, Department of Internal Medicine (O.T., V.S., D.W.-F., E.L., H.D., T.R.P., B.O.-P.);
Clinical Institute of Medical and Chemical Laboratory Diagnostics (W.R.); and
Ear, Nose, and Throat University Hospital, Department of Phoniatrics (M.G.), Medical University of Graz, 8036 Graz, Austria
Address all correspondence and requests for reprints to: Barbara Obermayer-Pietsch, Prof., M.D., Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria. barbara.obermayer@medunigraz.at.
The Journal of Clinical Endocrinology & Metabolism April 24, 2012 jc.2011-3088

Context: Low 25-hydroxycholecalciferol [25(OH) vitamin D] status is known to play an important role in many diseases with focus on bone health.

Objective: Based on recently reported genetic determinants of vitamin D insufficiency, we aimed to analyze genetic variants of group-specific component (GC), 7-dehydrocholesterol reductase (DHCR7), and cytochrome P450IIR-1 (CYP2R1) for association with vitamin D levels, bone mineral density (BMD), and bone fractures.

Design: We conducted a cross-sectional BMD and fracture study and a prospective cohort study.

Setting: The cross-sectional study comprised participants of a BMD screening study, and the prospective cohort study comprised nursing home subjects.

Patients: The cross-sectional study included 342 subjects (mean age, 55.3 ± 12.0 yr), and the prospective study included 1093 subjects (mean age, 84.0 ± 6.0 yr).

Interventions: Patients were stratified by GC, DHCR7, and CYP2R1 genotypes. For each gene, the allele associated with lower 25(OH) vitamin D levels was designated as “risk allele.” The potential role of these risk alleles in fracture risk was analyzed by logistic regression analysis including age and sex as confounders.

Main Outcome Measures: We measured BMD and fractures.

Results: GC genotypes were significantly associated with lower mean 25(OH) vitamin D levels in both cohorts (P = 0.001 and P = 0.048, respectively).
There was no significant association of BMD with any of the genotypes. None of the alleles was associated with past fractures, whereas the DHCR7 G-allele was significantly associated with prospective fractures (odds ratio, 0.68; 95% confidence interval, 0.51–0.92; P = 0.011).

Conclusions: The DHCR7 gene polymorphism may be a predictor for fracture risk.

---

See also VitaminDWiki

• All items in category Genetics and Vitamin D 343 items
• All items in category Vitamin D Binding Protein (GC) and Vitamin D 178 items
• Search for DHCR7 in VitaminDWiki 64 items not in PDF as of Dec 2019
• Vitamin D insufficiency 2.5X more likely with three genes – Lancet July 2010
• CYP24A1 gene in cancer cells may actually deactivate vitamin D – Oct 2012
• Mice lacking CYP2R1 enzyme activate about half of much vitamin D – Sept 2013
• Pharmacology of vitamin D - April 2011 which has the following graphic

See also web

• Vitamin D-binding protein WikiPedia, which had the following image May 2013